Tag Archives: Ambry Genetics

June 2019—Ambry Genetics announced a laboratory services agreement with Clovis Oncology.

May 2018—ArcherDx and Ambry Genetics announced a partnership in which Ambry will provide biopharma sequencing services using ArcherDx’s next-generation sequencing assays. Ambry Genetics will utilize Archer Immunoverse and VariantPlex NGS assays to provide large-scale immune repertoire analysis and chimeric antigen receptor T-cell manufacturing characterization and pharmacodynamics to biopharma customers.

October 2017—Ambry Genetics and NorthShore University HealthSystem’s Center for Personalized Medicine (Evanston, Ill.) will partner to offer genetic testing and research to advance precision medicine in preventive care.

April 2016—Finding, fixing, and foiling shadow IT problems: The unsanctioned use of mobile devices and cloud-based software in the workplace, often referred to as shadow IT, is a pervasive problem. Yet, through education and enforcement of policies, it’s a problem that can be minimized.

March 2016—Ambry Genetics has launched a suite of five genetic tests for neurodevelopmental conditions: IDNext, a broad panel of 140 genes known to be associated with both syndromic and nonsyndromic intellectual disability; AutismFirst, a targeted panel of 16 genes recognized by the American College of Genetics and Genomics as associated with syndromic